TP-434-028: A PHASE 1, OPEN-LABEL, MULTICENTER STUDY TO DETERMINE THE PHARMACOKINETICS AND SAFETY OF INTRAVENOUS ERAVACYCLINE IN CHILDREN WITH SUSPECTED OR CONFIRMED BACTERIAL INFECTION

Project: Research project

Project Details

StatusActive
Effective start/end date10/31/18 → 10/30/50

Funding

  • Tetraphase Pharmaceuticals, Inc.